The 2021 Japanese Stroke Guidelines limit recommended drug classes to conventional agents such as angiotensin receptor blockers and angiotensin-converting enzyme inhibitors, calcium channel blockers, and diuretics [7]. The gene discussed is ACE; the disease is Stroke.